Keyphrases
Roux-en-Y Gastric Bypass
100%
Randomized Controlled Clinical Trial
100%
Glycemic Control
100%
Energy Expenditure
100%
Appetite Control
100%
Peptide YY3-36
20%
Glucagon-like
20%
Weight Loss
20%
Ghrelin
20%
Lower Body
10%
Hormone Secretion
10%
Energy Balance
10%
Per Se
10%
Low-calorie Diet
10%
Hepatic Insulin Clearance
10%
Bile Acids
10%
Signaling Molecules
10%
Early Change
10%
Glucose-tolerant
10%
Postprandial Glucose
10%
Negative Energy Balance
10%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
10%
Gastrointestinal Hormones
10%
Postprandial Response
10%
Fasting Plasma Glucose
10%
Control Sets
10%
Glucose Profile
10%
Cholecystokinin
10%
Body Composition
10%
Caloric Restriction
10%
Insulinogenic Index
10%
Disposition Index
10%
Blood Parameters
10%
Matsuda Index
10%
Pharmacology, Toxicology and Pharmaceutical Science
Controlled Clinical Trial
100%
Ghrelin
100%
Glucagon-Like Peptide-1
100%
Peptide YY [3-36]
100%
Fibroblast Growth Factor 19
50%
Bile Acid
50%
Cholecystokinin
50%
Gastrointestinal Hormone
50%
Insulin Resistance
50%
Medicine and Dentistry
Roux-en-Y Gastric Bypass
100%
Controlled Clinical Trial
100%
Energy Expenditure
100%
Glycemic Control
100%
Peptide YY [3-36]
20%
Glucagon Like Peptide 1
20%
Ghrelin
20%
Energy Balance
20%
Caloric Restriction
10%
Homeostatic Model Assessment
10%
Low Calorie Diet
10%
Gastrointestinal Hormone
10%
Insulin Resistance
10%
Hormone Release
10%
Fibroblast Growth Factor 19
10%
Bile Acid
10%
Insulin Clearance
10%
Cholecystokinin
10%
Signaling Molecule
10%
Biochemistry, Genetics and Molecular Biology
Controlled Clinical Trial
100%
Energy Expenditure
100%
Glycemic Control
100%
Energy Balance
25%
Ghrelin
25%
Glucagon-Like Peptide-1
25%
Gastrointestinal Hormone
12%
Bile Acid
12%
Body Composition
12%
Cholecystokinin
12%
Homeostasis
12%
Insulin Clearance
12%
Calorie
12%
Hormone Release
12%
Insulin Resistance
12%